Form DFRN14A - Revised definitive proxy statement filed by non-management:
SEC Accession No. 0000902664-19-003831
Filing Date
2019-09-26
Accepted
2019-09-26 17:00:30
Documents
3
Effectiveness Date
2019-09-26

Document Format Files

Seq Description Document Type Size
1 AMAG PHARMACEUTICALS, INC. p19-1966dfrn14a.htm DFRN14A 51012
2 GRAPHIC image_001.jpg GRAPHIC 4877
3 GRAPHIC image_002.jpg GRAPHIC 4513
  Complete submission text file 0000902664-19-003831.txt   65874
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Subject) CIK: 0000792977 (see all company filings)

EIN.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFRN14A | Act: 34 | File No.: 001-10865 | Film No.: 191118717
SIC: 2834 Pharmaceutical Preparations

Mailing Address 520 MADISON AVENUE NEW YORK NY 10022
Business Address 520 MADISON AVENUE NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

EIN.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFRN14A